GMP Consulting and the Pharmaceutical Industry

Many of the world's leading manufacturing centres ofdefects are examined, and the correct measures are
pharmaceutical and medical products have legislatedtaken so that all faulty products are recalled and the
that every pharmaceutical company under theirproblem will not arise again.
jurisdiction follow GMP procedures. The details of theGMP consulting is available to help companies set up
guidelines vary from country to country althoughtheir manufacture processes and to evaluate their
they all follow the same general principles. GMPbusiness before and after GMP audits. The
compliance assures the quality of medical products bypharmaceutical industry relies on GMP consulting as a
governing the production and distribution stages ofway to keep up with the complex and often
manufacture. It does this by following a series ofconfusing amount of legislation that covers the
assurances which monitor the production process.omedical sector. They are particularly important if a
The manufacturing processes are plainly defined andbusiness is expanding its operations in to foreign
controlled. All critical stages are validated to guaranteepremises. In the United States, GMPs are governed
consistency and compliance with specifications.o Ifby the Food and Drug Administration (FDA), the
there are any changes to these stages, they areWorld Health Organisation (WHO) have their own
evaluated. Changes that have an impact on theversion of GMP guidelines that are used by the
quality of the products are validated as required.o Allpharmaceutical industries in developing countries,
the instructions associated with each stage aremembers of the European Union have their own
written clearly and explicitly.o Operators are trainedGMPs, as do countries including Australia, Japan and
to carry out and document procedures to the exactCanada, which have their own sophisticated guidelines.
specification determined during the validationIn the UK, the Medicines Act (1968) covers most
process.o Records are kept, manually or byaspects of GMP and is known as 'The Rules and
computers during manufacture which exhibit that allGuidance for Pharmaceutical Manufacturers and
the steps required by the defined validationDistributors', or the 'Orange Guide' due to the colour
instructions were taken and that the number andof the document. This makes it very complicated for
quality of the drug was as expected. Deviationspharmaceutical companies with offices on more than
should be investigated and documented.o Records ofone continent as they may need different processes
manufacture (including distribution) that detail thein each base of manufacture.
complete history of any individual batch should beThe regulatory authorities in each country have the
retained in a comprehensible and accessible form inpower to make unannounced inspections of premises
case it needs to be traced at any time.o Theand products to ensure that patients are not put at
distribution of the medicines should not add any riskrisk from any bad practices. In the US, they have the
to their quality.o It should be possible to recall anypower to bring legal action against any company they
batch of the product from the market, even if thefind to be violating GMPs and the FDA actually
batch has been opened.o Complaints about medicinespublishes a list of companies and individuals who have
on the market are investigated, the causes of qualitybeen prosecuted or disciplined by them.